Brought to you by 
Eyetech Pharmaceuticals nets $146mm with IPO
18 Feb 2004
Executive Summary
Eyetech Pharmaceuticals has completed its initial public offering of 7.5mm common shares (including the overallotment). Each share was priced at $21 each, bringing in a net of $146mm.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Antisense, Oligonucleotides
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Eyetech Pharmaceuticals nets $146mm with IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice